KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Total Debt (2016 - 2025)

Historic Total Debt for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $12.9 billion.

  • Abbott Laboratories' Total Debt fell 1360.57% to $12.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 billion, marking a year-over-year decrease of 1360.57%. This contributed to the annual value of $14.1 billion for FY2024, which is 377.41% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Total Debt is $12.9 billion, which was down 1360.57% from $13.4 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Total Debt high stood at $18.3 billion for Q2 2021, and its period low was $12.9 billion during Q3 2025.
  • Its 5-year average for Total Debt is $15.9 billion, with a median of $16.4 billion in 2022.
  • Per our database at Business Quant, Abbott Laboratories' Total Debt skyrocketed by 97.96% in 2021 and then plummeted by 1369.23% in 2024.
  • Over the past 5 years, Abbott Laboratories' Total Debt (Quarter) stood at $18.0 billion in 2021, then decreased by 7.07% to $16.8 billion in 2022, then fell by 12.48% to $14.7 billion in 2023, then dropped by 3.77% to $14.1 billion in 2024, then fell by 8.38% to $12.9 billion in 2025.
  • Its Total Debt was $12.9 billion in Q3 2025, compared to $13.4 billion in Q2 2025 and $13.2 billion in Q1 2025.